Oct 16 (Reuters) - Abbott Laboratories ( ABT ) slightly

lifted its annual profit forecast on Wednesday, after beating

Wall Street estimates for quarterly earnings on strong sales of

its medical devices including its glucose-monitoring products.

The company now expects a full-year profit of $4.64 to $4.70

per share, with the midpoint a tad higher than that of its

earlier forecast of $4.61 to $4.71 per share.

On an adjusted basis, the company's quarterly profit of

$1.21 per share beat analysts' average expectations of $1.20 per

share, according to estimates compiled by LSEG.

(Reporting by Christy Santhosh and Leroy Leo in Bengaluru;

Editing by Devika Syamnath)